Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · IEX Real-Time Price · USD
8.49
-0.21 (-2.36%)
At close: Jul 19, 2024, 4:00 PM
8.55
+0.07 (0.77%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Terns Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for TERN stock have an average target of 14.5, with a low estimate of 5.50 and a high estimate of 23. The average target predicts an increase of 70.89% from the current stock price of 8.49.
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2024.
Analyst Ratings
The average analyst rating for TERN stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | -35.18% | May 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +76.78% | Apr 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | -35.18% | Apr 30, 2024 |
| UBS | UBS | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +112.14% | Mar 27, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +76.78% | Mar 18, 2024 |
Financial Forecast
Revenue This Year
1.99M
Revenue Next Year
2.58M
from 1.99M
Increased by 29.91%
EPS This Year
-1.35
from -1.27
EPS Next Year
-1.39
from -1.35
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.3M | 16.0M | 4.9M | 38.0M | 41.3M |
| Avg | 2.0M | 2.6M | 1.2M | 12.3M | 14.7M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 702.4% | 91.0% | 3,070.1% | 235.3% |
| Avg | - | 29.9% | -53.6% | 926.5% | 19.6% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.22 | -1.07 | -0.99 | -0.69 | -0.23 |
| Avg | -1.35 | -1.39 | -1.31 | -1.07 | -0.97 |
| Low | -1.43 | -1.59 | -1.49 | -1.70 | -1.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.